Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cotter

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|May 26, 2004
Neurological soft signs and dermatoglyphic anomalies in twins with schizophreniaBrendan D Kelly, David Cotter, Cian Denihan, et al.
Schizophrenia Research|June 10, 2020
Functional impairment of cortical AMPA receptors in schizophreniaTommaso Zeppillo, Anton Schulmann, Fabio Macciardi, et al.
Behavioural Brain Research|August 21, 2007
Exploratory and habituation phenotype of heterozygous and homozygous COMT knockout miceDaniela Babovic, Colm M O'Tuathaigh, Gerard J O'Sullivan, et al.
Translational Psychiatry|October 6, 2023
Chronic treatment with D2-antagonist haloperidol leads to inhibitory/excitatory imbalance in striatal D1-neuronsCátia Santa, Diana Rodrigues, Joana F Coelho, et al.
Pediatrics|May 11, 2025
Stimulant Medication Use and Risk of Psychotic ExperiencesKirstie O'Hare, Jonah F Byrne, Hugh Ramsay, et al.
Dermatology Online Journal|February 23, 2026
31-Gene expression profiling for cutaneous melanoma: an expert consensus panelJoshua Burshtein, Clay Cockerell, David Cotter, et al.
Psychiatry Research. Neuroimaging|April 6, 2025
Cognitive outcomes and performance of patients diagnosed and treated for N-Methyl-D-Aspartate receptor antibody-mediated (NMDAR) encephalitis compared with patients with schizophrenia and healthy controlsEric Kelleher, David Mothersill, April Hargreaves, et al.
BMC Public Health|February 2, 2023
Investigating the effectiveness of three school based interventions for preventing psychotic experiences over a year period - a secondary data analysis study of a randomized control trialLorna Staines, Colm Healy, Paul Corcoran, et al.
BMC Public Health|March 24, 2023
Correction to: Investigating the effectiveness of three school based interventions for preventing psychotic experiences over a year period - a secondary data analysis study of a randomized control trialLorna Staines, Colm Healy, Paul Corcoran, et al.
Brain, Behavior, and Immunity|January 14, 2024
Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptomsColm Healy, Jonah Byrne, Subash Raj Suasi, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
European Psychiatry : the Journal of the Association of European Psychiatrists|May 26, 2004
Neurological soft signs and dermatoglyphic anomalies in twins with schizophreniaBrendan D Kelly, David Cotter, Cian Denihan, et al.
Schizophrenia Research|June 10, 2020
Functional impairment of cortical AMPA receptors in schizophreniaTommaso Zeppillo, Anton Schulmann, Fabio Macciardi, et al.
Behavioural Brain Research|August 21, 2007
Exploratory and habituation phenotype of heterozygous and homozygous COMT knockout miceDaniela Babovic, Colm M O'Tuathaigh, Gerard J O'Sullivan, et al.
Translational Psychiatry|October 6, 2023
Chronic treatment with D2-antagonist haloperidol leads to inhibitory/excitatory imbalance in striatal D1-neuronsCátia Santa, Diana Rodrigues, Joana F Coelho, et al.
Pediatrics|May 11, 2025
Stimulant Medication Use and Risk of Psychotic ExperiencesKirstie O'Hare, Jonah F Byrne, Hugh Ramsay, et al.
Dermatology Online Journal|February 23, 2026
31-Gene expression profiling for cutaneous melanoma: an expert consensus panelJoshua Burshtein, Clay Cockerell, David Cotter, et al.
Psychiatry Research. Neuroimaging|April 6, 2025
Cognitive outcomes and performance of patients diagnosed and treated for N-Methyl-D-Aspartate receptor antibody-mediated (NMDAR) encephalitis compared with patients with schizophrenia and healthy controlsEric Kelleher, David Mothersill, April Hargreaves, et al.
BMC Public Health|February 2, 2023
Investigating the effectiveness of three school based interventions for preventing psychotic experiences over a year period - a secondary data analysis study of a randomized control trialLorna Staines, Colm Healy, Paul Corcoran, et al.
BMC Public Health|March 24, 2023
Correction to: Investigating the effectiveness of three school based interventions for preventing psychotic experiences over a year period - a secondary data analysis study of a randomized control trialLorna Staines, Colm Healy, Paul Corcoran, et al.
Brain, Behavior, and Immunity|January 14, 2024
Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptomsColm Healy, Jonah Byrne, Subash Raj Suasi, et al.
Pageof 10